Platelet CD36 is at the intersection of inflammation and arterial thrombosis

[ASH Special Lecture] Platelet CD36 is at the intersection of inflammation and arterial thrombosis

Roy L Silverstein^1,2, Moua Yang^1,2,3 (1.Medical College of Wisconsin, Department of Medicine, United States of America, 2.Blood Research Institute, Versity Blood Center of Wisconsin, United States of America, 3.Department of Biochemistry, Medical College of Wisconsin, United States of America)

Roy L. Silverstein, MD, FACP, is Chair of the Department of Medicine at the Medical College of Wisconsin (MCW) in Milwaukee, where he also serves as the Associate Director for the MCW Cancer Center. Dr. Silverstein is also Senior Investigator for the Blood Research Institute at the Versiti Blood Center of Wisconsin. He earned his medical degree from Emory University in Atlanta and completed his training in internal medicine and hematology/oncology at the New York-Presbyterian/Weill Cornell Medical College. Currently, Dr. Silverstein is the President of the American Society of Hematology. Dr. Silverstein’s research interests include clinical non-malignant hematology; translational research on the molecular, cellular, and genetic causes of thrombosis; angiogenesis; and atherosclerosis. Dr. Silverstein is a member of the American Society for Clinical Investigation and Association of American Professors and has received several prestigious awards, including the New York Weill Cornell Medical Center Alumni Council Distinguished Achievement Award as well as the Russell Ross Lecture in Vascular Biology from the American Heart Association.